AGM Statement

RNS Number:3063D
Maelor PLC
05 September 2007



                                   Maelor plc



                                 AGM Statement





5 September 2007: Maelor plc ("Maelor" or the "Company", AIM: MLR), the
specialist hospital medicines business, is today providing the following update
on current trading at its Annual General Meeting:



"In June we announced the Company's results for the financial year ended 31
March 2007 and noted that it had been a year of significant achievements for
Maelor. Under the leadership of our CEO, Tim Wright, we transformed Maelor into
a profitable business with a focus on late stage specialist hospital medicines,
leveraging our expertise in both pharmaceuticals and medical devices.



This progress has continued into the current financial year with the Company
maintaining its strategy and delivering encouraging trading in line with the
board's expectations.



Since the year end we announced the transforming and synergistic acquisition of
Acorus Therapeutics Limited ("Acorus"), a specialist pharmaceuticals and medical
devices company. The acquisition has created a strong, enlarged Group. We have
successfully completed the integration of the Acorus business into our portfolio
and some of the immediate benefits of this will be reflected in the forthcoming
interim accounts for the period ending 30 September 2007.



At the same time as developing market opportunities for our increased range of
products both in the UK and overseas, we are aggressively pursuing our plans to
grow the enlarged portfolio through direct promotion and effective partnerships.
In addition to this, in line with our strategic ambitions, we are actively
seeking to develop the Company through further acquisitions."



Enquiries:

Financial Dynamics Limited              [phone]
Billy Clegg / Edward Westropp

Noble & Company Limited                 [phone]
Matthew Hall/Sam Reynolds

Maelor plc                              [phone]
Tim Wright




                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

AGMSSWFALSWSESU